Geoffrey Rose published The Strategy of Preventive Medicine in 1992 and thus gave birth to the "Population Health" movement. This podcast episode critically examines Rose's influential ideas.

Many physicians feel ambivalent about assisted suicide and neither endorse the practice nor outright condemn it. As a result, they also avoid discussing the topic altogether. Our guest is Dr. Adam Cifu, who kindly agreed to engage in a conversation on this difficult question.

Our guest is the highly successful and widely respected blogger who writes anonymously under the pen name “Skeptical Scalpel.” He is a former Chairman of Surgery at an academic institution and we conversed about the state of surgical education and its present-day challenges.

Should the medical school curriculum include health inequity, climate change, and gun control? Our guest is Professor Stanley Goldfarb, author of a recent and controversial op-ed in the Wall Street Journal on the politicization of medical education.

As a follow-up to our podcast on the Ranbaxy Scandal, we are joined by medicinal chemist John Tucker, PhD and hypertension specialist Swapnil Hiremath, MD. Our distinguished guests share with us their perspectives and impressions on the unsettling question of generic drugs.

Generic drugs represent 90% of the pharmaceutical market. Their use has been encouraged through decades of favorable legislation and subsidies, with authorities claiming they are as safe and effective as brand name drugs. Yet generic preparations tainted with impurities are being reported with increasing frequency. What should doctors and the public know about generic drug manufacture? Our guest is the chemist who was at the center of the most important scandal to rock the global pharmaceutical industry in decades.

A health policy of choice—not of constraints—is what we need, says our guest David Balat.  He is currently the Director of the Right on Healthcare initiative with Texas Public Policy Foundation. He has a broad base of experience throughout the healthcare spectrum with special expertise in healthcare finance. He is a former Congressional candidate in Texas’…

As a medical discipline, psychiatry has often been the target of severe criticism, particularly in the last 50 to 60 years.  Is the criticism valid or not?  What is the outlook for the science of mental illness and the practice of psychiatry?  Our guest today defends his chosen medical specialty. George Dawson, MD, DFAPA, is…

Will the randomized control trial bring more clarity and certainty to economic science?  Is “evidence-based economics” something to be hailed as a welcome innovation or should it be appraised with a more sober attitude?  To examine this topic and discuss the relative place of randomized trials in economics and medicine we have as our guest…